Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

NCT05442216

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Miami Miami, Florida, United States
  • AdventHealth Orlando Orlando, Florida, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

NCT04588922

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • O'Neal Comprehensive Cancer Center, University of Alabama Birmingham, Alabama, United States
  • City of Hope - Phoenix Goodyear, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 26 locations
View Trial Details
Recruiting

First-in-human (FIH) Trial of GEN3018 in Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) or Higher-risk Myelodysplastic Syndrome (HR-MDS)

NCT07384715

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Aarhus Universitetshospital - Skejby Aarhus, Denmark
  • Copenhagen Rigshospitalet Copenhagen, Denmark
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
  • Hospital Clínic de Barcelona Barcelona, Spain
View Trial Details
Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

NCT07012044

Conditions
Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • C S Mott Children's Hospital Ann Arbor, Michigan, United States
  • University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07216443

Conditions
Acute Disease, Bone Marrow Diseases, Disease, +24 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Weill Cornell Medicine - New York Presbyterian Hospital New York, United States
View Trial Details

Related conditions